Celltrion
068270.KS
#659
Rank
A$55.35 B
Marketcap
A$241.56
Share price
3.61%
Change (1 day)
25.05%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): A$4.79

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$4.85. In 2025 the company made an earnings per share (EPS) of A$4.60 an increase over its 2024 EPS that were of A$1.75.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$4.794.07%
2025A$4.60163.66%
2024A$1.75-53.73%
2023A$3.77-2.08%
2022A$3.85-11.72%
2021A$4.372.03%
2020A$4.2882.8%
2019A$2.3418.31%
2018A$1.98-36.33%
2017A$3.11161.25%
2016A$1.192.86%
2015A$1.1617.84%
2014A$0.985.87%
2013A$0.93-70.85%
2012A$3.18134.09%
2011A$1.3643.59%
2010A$0.9574.49%
2009A$0.54317.8%
2008A$0.13-71.7%
2007A$0.46